Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme
Open Access
- 1 August 1994
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (2), 239-243
- https://doi.org/10.1038/bjc.1994.286
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Reversal of the Malignant Phenotype by an Anti-ras RibozymeAntisense Research and Development, 1992
- A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.Proceedings of the National Academy of Sciences, 1987
- ATP‐binding properties of P glycoprotein from multidrug‐resistant KB cellsThe FASEB Journal, 1987
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.Proceedings of the National Academy of Sciences, 1987
- Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- BIOLOGICAL CATALYSIS BY RNAAnnual Review of Biochemistry, 1986
- Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells.Proceedings of the National Academy of Sciences, 1986
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976